Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors

Aim: In percutaneous coronary intervention (PCI)-treated acute coronary syndrome (ACS) patients on clopidogrel therapy, high on-treatment platelet adenosine diphosphate (ADP) reactivity was observed in numerous studies, with significant increases in non-fatal myocardial infarction, definite/probable...

Descripción completa

Detalles Bibliográficos
Autores principales: Ristorto, Jessica, Messas, Nathan, Marchandot, Benjamin, Kibler, Marion, Hess, Sébastien, Meyer, Nicolas, Schaeffer, Michael, Tuzin, Nicolas, Ohlmann, Patrick, Jesel, Laurence, Morel, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099071/
https://www.ncbi.nlm.nih.gov/pubmed/29415954
http://dx.doi.org/10.5551/jat.40584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099071/
https://www.ncbi.nlm.nih.gov/pubmed/29415954
http://dx.doi.org/10.5551/jat.40584

Ejemplares similares